It looks like you're offline.
Open Library logo
additional options menu

MARC Record from Library of Congress

Record ID marc_loc_2016/BooksAll.2016.part36.utf8:90595500:4145
Source Library of Congress
Download Link /show-records/marc_loc_2016/BooksAll.2016.part36.utf8:90595500:4145?format=raw

LEADER: 04145cam a22004574a 4500
001 2008939423
003 DLC
005 20100309091850.0
008 081014s2009 nyua b 001 0 eng c
010 $a 2008939423$z 2008931190
015 $aGBA889185$2bnb
016 7 $a101495311$2DNLM
016 7 $a014669529$2Uk
020 $a9781603275460 (hbk. : alk. paper)
020 $a1603275460 (hbk. : alk. paper)
020 $a9781603275477 (e-ISBN)
020 $a1603275479 (e-ISBN)
035 $a(OCoLC)ocn233934523
040 $aNLM$cNLM$dUKM$dBTCTA$dBAKER$dYDXCP$dCUS$dBWX$dCDX$dCOU$dDLC$dIG#$dZWZ$dDLC
042 $apcc
050 00 $aQP623.5.S63$bS57 2009
060 00 $aW1$bME9616J v.487 2009
060 10 $aQU 58.7$bS621 2009
245 00 $asiRNA and miRNA gene silencing :$bfrom bench to bedside /$cedited by Mouldy Sioud.
260 $aNew York, NY :$bHumana Press ;$aLondon :$bSpringer [distributor],$cc2009.
300 $axiv, 472 p. :$bill. ;$c27 cm.
490 1 $aMethods in molecular biology ;$v487
490 1 $aSpringer protocols
504 $aIncludes bibliographical references and index.
505 0 $aMethods for selecting effective siRNA sequences by using statistical and clustering techniques / Shigeru Takasaki -- Deciphering the code of innate immunity recognition of siRNAs / Mouldy Sioud -- Targeted delivery of anitsense oligonucleotides and siRNAs into mammalian cells / Mouldy Sioud -- Local and systemic delivery of siRNAs for oligonucleotide therapy / Fumitaka Takeshita ... [et al.] -- Imaging of siRNA delivery and silencing / Anna Moore and Zdravka Medarova -- Recent advances in magnetofection and its potential to deliver siRNAs in vitro / Olga Mykhaylyk ... [et al.] -- In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi) / Shuanglin Xiang ... [et al.] -- Bacterial delivery of siRNAs : a new approach to solid tumor therapy / De-Qi Xu ... [et al.] -- The therapeutic potential of LNA-modified siRNAs : reduction of off-target effects by chemical modification of the siRNA sequence / Kees Fluiter, Olaf R.F. Mook, and Frank Baas -- pSM155 and pSM30 vectors for miRNA and shRNA expression / Junzhu Wu, Akua N. Bonsra, and Guangwei Du -- Targeting oncogenes with siRNAs / Olaf Heidenreich -- Targeting stromal-cancer cell interactions with siRNAs / Seyedhossein Aharinejad ... [et al.] -- Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases / Christopher S. Gondi and Jasti S. Rao -- Silencing of HIF-1[alpha] by RNA interference in human glioma cells in vitro and in vivo / David L. Gillespie ... [et al.] -- RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets / Marco Folini, Marzia Pennati, and Nadia Zaffaroni -- Treating respiratory viral diseases with chemically modified, second generaton intranasal siRNAs/ Sailen Barik -- Progress in the therapeutic applications of siRNAs against HIV-1 / Miguel Angel Martínez -- Protein components of the microRNA pathway and human diseases / Marjorie P. Perron and Patrick Provost -- Intron-mediated RNA interference and microRNA biogenesis / Shao-Yao Ying and Shi-Lung Lin -- Emergence of a complex relationship between HIV-1 and the microRNA pathway / Dominique L. Ouellet ... [et al.] -- Synthetic microRNA targeting glioma-associated antigen-1 protein / Naotake Tsuda ... [et al.] -- Therapeutic targeting of gene expression by siRNAs directed against BCR-ABL transcripts in a patient with Imatinib-resistant chronic myeloid leukemia / Michael Koldehoff and Ahmet H. Elmaagacli.
650 0 $aSmall interfering RNA.
650 0 $aGene silencing.
650 12 $aRNA, Small Interfering$xtherapeutic use.
650 22 $aGene Silencing.
650 22 $aMicroRNAs$xtherapeutic use.
650 17 $aPetit ARN d'interférence$xusage thérapeutique.$2fmesh
650 27 $aInactivation d'un gène.$2fmesh
650 27 $aInterférence ARN.$2fmesh
700 1 $aSioud, Mouldy.
830 0 $aMethods in molecular biology (Clifton, N.J.) ;$vv. 487.
830 0 $aSpringer protocols.